TY - JOUR
T1 - A Peptide Antagonist of ErbB Receptors, Inherbin3, Induces Neurite Outgrowth from Rat Cerebellar Granule Neurons Through ErbB1 Inhibition
AU - Xu, Ruodan
AU - Pankratova, Stanislava
AU - Christiansen, Søren Hofman Oliveira
AU - Woldbye, David Paul Drucker
AU - Højland, Anne
AU - Bock, Elisabeth Marianne
AU - Berezin, Vladimir
PY - 2013
Y1 - 2013
N2 - rbB receptors not only function in cancer, but are also key developmental regulators in the nervous system. We previously identified an ErbB1 peptide antagonist, Inherbin3, that is capable of inhibiting tumor growth in vitro and in vivo. In this study, we found that inhibition of ErbB1 kinase activity and activation of ErbB4 by NRG-1β induced neurite extension, suggesting that ErbB1 and ErbB4 act as negative and positive regulators, respectively, of the neuritogenic response. Inherbin3, inhibited activation not only of ErbB1 but also of ErbB4 in primary neurons, strongly induced neurite outgrowth in rat cerebellar granule neurons, indicating that this effect mainly was due to inhibition of ErbB1 activation.
AB - rbB receptors not only function in cancer, but are also key developmental regulators in the nervous system. We previously identified an ErbB1 peptide antagonist, Inherbin3, that is capable of inhibiting tumor growth in vitro and in vivo. In this study, we found that inhibition of ErbB1 kinase activity and activation of ErbB4 by NRG-1β induced neurite extension, suggesting that ErbB1 and ErbB4 act as negative and positive regulators, respectively, of the neuritogenic response. Inherbin3, inhibited activation not only of ErbB1 but also of ErbB4 in primary neurons, strongly induced neurite outgrowth in rat cerebellar granule neurons, indicating that this effect mainly was due to inhibition of ErbB1 activation.
U2 - 10.1007/s11064-013-1166-1
DO - 10.1007/s11064-013-1166-1
M3 - Journal article
C2 - 24132641
VL - 38
SP - 2550
EP - 2558
JO - Neurochemical Research
JF - Neurochemical Research
SN - 0364-3190
IS - 12
ER -